JGC
MDCO

J. Goldman & Co’s Medicines Co MDCO Stock Holding History

J. Goldman & Co’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-140,000
Closed -$4M – 330
2015
Q2 		$4M Buy
140,000
+28,000
+25% +$780K 0.24% 112
2015
Q1 		$3.14M Buy
+112,000
New +$3.15M 0.19% 142
2014
Q1 		– Sell
-185,000
Closed -$7.14M – 318
2013
Q4 		$7.14M Sell
185,000
-62,400
-25% -$2.23M 0.9% 21
2013
Q3 		$8.29M Buy
+247,400
New +$7.88M 0.78% 26

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

J. Goldman & Co's MDCO Position: Q4 2016 in Review

J. Goldman & Co sold out of Medicines Co (MDCO) in Q4 2016, closing a stake of 88,400 shares — an estimated $3.34M sold.

J. Goldman & Co first reported a position in MDCO in Q3 2013 and held it in 8 quarters. The position peaked at $12M in Q1 2014. 195 funds tracked by Wall St. Rank hold MDCO as of Q4 2016.

  • J. Goldman & Co reported no remaining Medicines Co position as of Q4 2016 after selling out during the quarter.
  • J. Goldman & Co sold 88,400 Medicines Co shares in Q4 2016, an estimated $3.34M.
  • J. Goldman & Co first reported a position in Medicines Co in Q3 2013 and held it in 8 quarters.
  • J. Goldman & Co's Medicines Co position peaked at $12M in Q1 2014.
  • 195 funds tracked by Wall St. Rank held Medicines Co as of Q4 2016.

Based on J. Goldman & Co's 13F filing for Q4 2016, filed 13 Feb 2017.